Author Correction: ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway

Sha Li; Hong Yang; Wan Li; Jin-Yi Liu; Li-Wen Ren; Yi-Hui Yang; Bin-Bin Ge; Yi-Zhi Zhang; Wei-Qi Fu; Xiang-Jin Zheng; Guan-Hua Du; Jin-Hua Wang

doi:10.1038/s41401-024-01319-3

Author Correction: ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway

Acta Pharmacol Sin. 2024 Nov;45(11):2450-2451. doi: 10.1038/s41401-024-01319-3.

Authors

Sha Li^{1

2}, Hong Yang^{1

2}, Wan Li^{1

2}, Jin-Yi Liu^{1

2}, Li-Wen Ren^{1

2}, Yi-Hui Yang^{1

2}, Bin-Bin Ge^{1

2}, Yi-Zhi Zhang^{1

2}, Wei-Qi Fu^{1

2}, Xiang-Jin Zheng^{1

2}, Guan-Hua Du^{3

4}, Jin-Hua Wang^{5

6}

Affiliations

¹ The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.
² Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China.
³ The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China. [email protected].
⁴ Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China. [email protected].
⁵ The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China. [email protected].
⁶ Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China. [email protected].

PMID: 38918585
PMCID: PMC11489664 (available on 2025-11-01)
DOI: 10.1038/s41401-024-01319-3

No abstract available

Publication types

Published Erratum